Bank of America
ORMP icon

Bank of America’s Oramed Pharmaceuticals ORMP Stock Holding History

Bank of America’s Portfolio ORMP Stock Details ORMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$497K Buy
146,152
+3,909
+3% +$13.3K ﹤0.01% 4898
2025
Q4 		$405K Sell
142,243
-7,424
-5% -$19.1K ﹤0.01% 5025
2025
Q3 		$395K Buy
149,667
+6,261
+4% +$13.8K ﹤0.01% 5934
2025
Q2 		$323K Sell
143,406
-20,289
-12% -$44.7K ﹤0.01% 5949
2025
Q1 		$350K Sell
163,695
-3,958
-2% -$9.13K ﹤0.01% 5853
2024
Q4 		$406K Sell
167,653
-4,539
-3% -$10.8K ﹤0.01% 5696
2024
Q3 		$420K Sell
172,192
-1,049
-0.6% -$2.56K ﹤0.01% 5600
2024
Q2 		$445K Sell
173,241
-113,811
-40% -$270K ﹤0.01% 5415
2024
Q1 		$838K Buy
287,052
+15,649
+6% +$43.8K ﹤0.01% 5044
2023
Q4 		$627K Buy
271,403
+250,866
+1,222% +$536K ﹤0.01% 5329
2023
Q3 		$53.6K Sell
20,537
-11,374
-36% -$35.8K ﹤0.01% 6483
2023
Q2 		$114K Sell
31,911
-25,375
-44% -$81.4K ﹤0.01% 6143
2023
Q1 		$125K Buy
57,286
+38,429
+204% +$122K ﹤0.01% 6162
2022
Q4 		$227K Sell
18,857
-6,220
-25% -$48.4K ﹤0.01% 5846
2022
Q3 		$163K Sell
25,077
-14,660
-37% -$119K ﹤0.01% 6101
2022
Q2 		$182K Sell
39,737
-30,874
-44% -$165K ﹤0.01% 6156
2022
Q1 		$611K Sell
70,611
-12,919
-15% -$132K ﹤0.01% 5674
2021
Q4 		$1.19M Buy
83,530
+60,717
+266% +$1.27M ﹤0.01% 5056
2021
Q3 		$502K Buy
22,813
+3,209
+16% +$54.7K ﹤0.01% 5635
2021
Q2 		$263K Buy
19,604
+2,035
+12% +$23.3K ﹤0.01% 5893
2021
Q1 		$178K Buy
17,569
+4,048
+30% +$33.2K ﹤0.01% 6110
2020
Q4 		$57K Buy
13,521
+12,821
+1,832% +$41.7K ﹤0.01% 6275
2020
Q3 		$2K Hold
700
– – ﹤0.01% 6703
2020
Q2 		$2K Sell
700
-43
-6% -$144 ﹤0.01% 6677
2020
Q1 		$2K Sell
743
-374
-33% -$1.64K ﹤0.01% 6640
2019
Q4 		$6K Hold
1,117
– – ﹤0.01% 6738
2019
Q3 		$4K Sell
1,117
-119
-10% -$396 ﹤0.01% 6896
2019
Q2 		$4K Buy
1,236
+119
+11% +$420 ﹤0.01% 6873
2019
Q1 		$4K Hold
1,117
– – ﹤0.01% 6831
2018
Q4 		$3K Hold
1,117
– – ﹤0.01% 6848
2018
Q3 		$5K Hold
1,117
– – ﹤0.01% 6832
2018
Q2 		$8K Hold
1,117
– – ﹤0.01% 6708
2018
Q1 		$7K Hold
1,117
– – ﹤0.01% 6703
2017
Q4 		$10K Hold
1,117
– – ﹤0.01% 6605
2017
Q3 		$11K Hold
1,117
– – ﹤0.01% 6509
2017
Q2 		$9K Hold
1,117
– – ﹤0.01% 6456
2017
Q1 		$7K Buy
1,117
+200
+22% +$1.24K ﹤0.01% 6616
2016
Q4 		$6K Buy
917
+400
+77% +$2.6K ﹤0.01% 6665
2016
Q3 		$4K Buy
517
+417
+417% +$3.24K ﹤0.01% 6680
2016
Q2 		$1K Hold
100
– – ﹤0.01% 6999
2016
Q1 		$1K Hold
100
– – ﹤0.01% 6871
2015
Q4 		$1K Sell
100
-5,000
-98% -$37.9K ﹤0.01% 7193
2015
Q3 		$28K Buy
5,100
+5,000
+5,000% +$31.4K ﹤0.01% 6200
2015
Q2 		$1K Hold
100
– – ﹤0.01% 7138
2015
Q1 		$1K Hold
100
– – ﹤0.01% 6831
2014
Q4 		$0 Buy
+100
New +$658 ﹤0.01% 7867
2014
Q3 		– Sell
-3,000
Closed -$29K – 8122
2014
Q2 		$29K Sell
3,000
-3,000
-50% -$30.6K ﹤0.01% 6990
2014
Q1 		$70K Buy
+6,000
New +$101K ﹤0.01% 6237

Other funds holding ORMP

BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
AF
Aquamarine Financial George Town $1.37B AUM
Mercer Global Advisors
Mercer Global Advisors Denver, Colorado $67.6B AUM 18.3% 1-Year Est. Return
GIA
Gem Investment Advisors Teaneck, New Jersey $102M AUM
M
Murchinson Toronto, Ontario, Canada $791M AUM 68.08% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
RG
Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Bank of America's ORMP Position: Q1 2026 in Review

Bank of America increased its Oramed Pharmaceuticals (ORMP) stake by 2.7% in Q1 2026, buying an estimated $13.3K and bringing the position to 146,152 shares worth $497K. The position accounts for ﹤0.01% of the portfolio, ranked #4898.

Bank of America first reported a position in ORMP in Q1 2014 and has held it in 48 quarters since. The position peaked at $1.19M in Q4 2021. 64 funds tracked by Wall St. Rank hold ORMP as of Q1 2026.

  • Bank of America held 146,152 shares of Oramed Pharmaceuticals worth $497K as of Q1 2026.
  • Bank of America bought 3,909 Oramed Pharmaceuticals shares in Q1 2026, an estimated $13.3K.
  • Oramed Pharmaceuticals made up ﹤0.01% of Bank of America's portfolio in Q1 2026, its #4898 holding.
  • Bank of America first reported a position in Oramed Pharmaceuticals in Q1 2014 and has held it in 48 quarters since.
  • Bank of America's Oramed Pharmaceuticals position peaked at $1.19M in Q4 2021.
  • 64 funds tracked by Wall St. Rank held Oramed Pharmaceuticals as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.